Remodeling of Human Transplanted Myocardium in Ten-Year Follow-Up: A Clinical Pathology Study

Transplantation Proceedings

Volumn 39, Issue 9, 2007, Pages 2833-2840

  Nozynski J ^a   Zakliczynski M ^a   Zembala Nozynska E ^a   Konecka Mrowka D ^a   Przybylski, R ^a   Nikiel, B ^b   Lange, D ^b   Mrowka A ^a   Przybylski, J ^a   Maruszewski, M ^a   Zembala, M ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROBLAST; FOLLOW UP; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE WALL; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HEART TRANSPLANTATION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

BIOPSY; CELL DIVISION; CELL NUCLEUS; DIASTOLE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEART TRANSPLANTATION; HEART VENTRICLES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYOCARDIUM; MYOCYTES, CARDIAC; RETROSPECTIVE STUDIES; SARCOPLASMIC RETICULUM; TIME FACTORS; VENTRICULAR REMODELING;

EID: 36048992475     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.08.074     Document Type: Article

References (23)

1. Cohen I.G., Hoyt E.G., and Billingham M.E. Myocardial fibrosis due to cyclosporine in rat heterotopic heart transplantation. Heart Transplant 3 (1984) 355
2. Stewart S., and Cary N. The pathology of heart and heart and lung transplantation-an update. J Clin Pathol 44 (1991) 803
3. Billingham M.E. Cardiac transplant atherosclerosis. Transplant Proc 19 (1987) 19
4. Furukawa Y., Libby P., Stinn J.L., et al. Cold ischemia induces isograft arteriopathy, but does not augment allograft arteriopathy in non- immunosuppressed hosts. Am J Pathol 160 (2002) 1077
5. Olivetti G., Giordano G., Corradi D., et al. Gender differences and ageing: effects on the human heart. J Am Coll Cardiol 26 (1995) 1068
6. Anversa P., Kajstura J., and Olivetti G. Myocyte death in heart failure. Curr Opin Cardiol 11 (1995) 245
7. Chen Q.M., and Tu V.C. Apoptosis and heart failure: mechanisms and therapeutic implications. Am J Cardiovasc Drugs 2 (2002) 43
8. Cheng W., Li B., Kajstura J., et al. Stretch-induced programmed myocyte cell death. J Clin Invest 96 (1995) 2247
9. Desrois M., Durrans A., Caus T., et al. Modulation of the NO pathway during short or prolonged blood reperfusion following ischemia in heterotopic rat heart transplantation model. Transplant Proc 36 (2004) 1280
10. Liu Y., Cigola E., Cheng W., et al. Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. Lab Invest 73 (1995) 771
11. Billingham M.E., Cary N.R.B., Hammond M.E., et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. J Heart Transplant 9 (1990) 587
12. Kemnitz J., Cohnert T., Schaefers H.J., et al. A classification of cardiac allograft rejection. A modification of the classification by Billingham. Am J Surg Pathol 11 (1987) 503
13. Buzas K., Megyeri K., Hogye M., et al. Comparative study of the roles of cytokines and apoptosis in dilated and hypertrophic cardiomyopathies. Eur Cytokine Netw 15 (2004) 53
14. Stetson S.J., Perez-Verdia A., Mazur W., et al. Cardiac hypertrophy after transplantation is associated with persistent expression of tumor necrosis factor-alpha. Circulation 104 (2001) 676
15. Nagueth S.F., Stetson S.J., Lakkis N.M., et al. Decreased expression of tumor necrosis factor-alpha and regression of hypertrophy after nonsurgical septal reduction therapy for patients with hypertrophic obstructive cardiomyopathy. Circulation 103 (2001) 1844
16. Rowan R.A., and Billingham M.E. Pathologic changes in the long-term transplanted heart: a morphometric study of myocardial hypertrophy, vascularity and fibrosis. Hum Pathol 21 (1990) 768
17. Quanini F., Cigola E., Lagrasta C., et al. End-stage failure in humans is coupled with the induction of proliferating cell nuclear antigen and nuclear mitotic division in ventricular myocytes. Circ Res 75 (1994) 1050
18. Yan S.M., Finato N., Artico D., et al. DNA content, apoptosis and mitosis in transplanted human hearts. Adv Clin Path 2 (1998) 205
19. Matsuura K., Wada H., Nagai T., et al. Cardiomyocytes fuse with surrounding noncardiomyocytes and reenter the cell cycle. J Cell Biol 167 (2004) 351
20. Imakita M., Tazelaar H.D., Rowan R.A., et al. Myocyte hypertrophy in the transplanted hearts. A morphometric analysis. Transplantation 43 (1987) 839
21. Baandrup U., and Olsen E.G.J. Critical analysis of endomyocardial biopsies from patients suspected to having cardiomyopathy. I. Morphological and morphometric aspects. Br Heart J 45 (1981) 475
22. Olsen E.G.J. Morphological evaluation (histologic, histochemical and ultrastructural) of endomyocardial biopsies. In: Bolte H.-D. (Ed). Myocardial biopsy: diagnostic significance (1980), Springer Verlag, Berlin 13
23. Rowan R.A., and Billingham M.E. Sustained myocardial hypertrophy seven years or more after heart transplantation: a morphometric study of endomyocardial specimens. J Heart Lung Transplant 11 (1992) 350